

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 8.75395458 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.43313109 |
| 3 | cytidine deamination (GO:0009972) | 8.27437905 |
| 4 | cytidine metabolic process (GO:0046087) | 8.27437905 |
| 5 | cytidine catabolic process (GO:0006216) | 8.27437905 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.03100603 |
| 7 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.39941342 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.83903225 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.83903225 |
| 10 | regulation of regulatory T cell differentiation (GO:0045589) | 4.60625078 |
| 11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.14153695 |
| 12 | proteasome assembly (GO:0043248) | 4.06819004 |
| 13 | protein neddylation (GO:0045116) | 4.04646146 |
| 14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.03073348 |
| 15 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.86803492 |
| 16 | respiratory electron transport chain (GO:0022904) | 3.82230336 |
| 17 | electron transport chain (GO:0022900) | 3.80830146 |
| 18 | sequestering of actin monomers (GO:0042989) | 3.71344729 |
| 19 | actin nucleation (GO:0045010) | 3.70909267 |
| 20 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.69204042 |
| 21 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.55677949 |
| 22 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.53742228 |
| 23 | positive regulation of interleukin-17 production (GO:0032740) | 3.47067976 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 3.43418129 |
| 25 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.42136351 |
| 26 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.42136351 |
| 27 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.40194824 |
| 28 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.40194824 |
| 29 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.40194824 |
| 30 | metallo-sulfur cluster assembly (GO:0031163) | 3.38549074 |
| 31 | iron-sulfur cluster assembly (GO:0016226) | 3.38549074 |
| 32 | negative regulation of T cell apoptotic process (GO:0070233) | 3.33067274 |
| 33 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.32751879 |
| 34 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.30623691 |
| 35 | termination of RNA polymerase III transcription (GO:0006386) | 3.30623691 |
| 36 | negative regulation of ligase activity (GO:0051352) | 3.25876214 |
| 37 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.25876214 |
| 38 | regulation of chronic inflammatory response (GO:0002676) | 3.23442996 |
| 39 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.22114558 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.21449300 |
| 41 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.19937262 |
| 42 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.19597800 |
| 43 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.19597800 |
| 44 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.14470619 |
| 45 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.12919554 |
| 46 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.08480610 |
| 47 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.06773829 |
| 48 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.06773829 |
| 49 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.02913594 |
| 50 | piRNA metabolic process (GO:0034587) | 3.01418639 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.95661319 |
| 52 | platelet dense granule organization (GO:0060155) | 2.93317316 |
| 53 | positive regulation of defense response to virus by host (GO:0002230) | 2.92870927 |
| 54 | positive regulation of tolerance induction (GO:0002645) | 2.92406162 |
| 55 | negative regulation of viral genome replication (GO:0045071) | 2.88034753 |
| 56 | respiratory chain complex IV assembly (GO:0008535) | 2.87369726 |
| 57 | protein complex biogenesis (GO:0070271) | 2.86345283 |
| 58 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.85944888 |
| 59 | DNA double-strand break processing (GO:0000729) | 2.84662894 |
| 60 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.83926344 |
| 61 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.83022845 |
| 62 | organelle disassembly (GO:1903008) | 2.82761165 |
| 63 | ATP biosynthetic process (GO:0006754) | 2.81002468 |
| 64 | rRNA modification (GO:0000154) | 2.78372078 |
| 65 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.77589866 |
| 66 | S-adenosylmethionine metabolic process (GO:0046500) | 2.77581091 |
| 67 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.77260537 |
| 68 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.76203349 |
| 69 | hydrogen ion transmembrane transport (GO:1902600) | 2.75886270 |
| 70 | centriole replication (GO:0007099) | 2.75878652 |
| 71 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.73775643 |
| 72 | negative regulation by host of viral transcription (GO:0043922) | 2.73500803 |
| 73 | regulation of cellular amine metabolic process (GO:0033238) | 2.73210396 |
| 74 | regulation of activation of Janus kinase activity (GO:0010533) | 2.71639455 |
| 75 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.69924514 |
| 76 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.68261384 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 2.67440607 |
| 78 | axoneme assembly (GO:0035082) | 2.67138533 |
| 79 | regulation of cilium movement (GO:0003352) | 2.66079166 |
| 80 | proton transport (GO:0015992) | 2.65709146 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 2.64594742 |
| 82 | cytochrome complex assembly (GO:0017004) | 2.63614829 |
| 83 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.63168138 |
| 84 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.61957851 |
| 85 | positive regulation of cell cycle arrest (GO:0071158) | 2.61885434 |
| 86 | hydrogen transport (GO:0006818) | 2.60825462 |
| 87 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.60368367 |
| 88 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.57309088 |
| 89 | protein deneddylation (GO:0000338) | 2.56775485 |
| 90 | positive regulation of ligase activity (GO:0051351) | 2.56325976 |
| 91 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.53405443 |
| 92 | histone mRNA metabolic process (GO:0008334) | 2.52689292 |
| 93 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.51411295 |
| 94 | mannosylation (GO:0097502) | 2.50313065 |
| 95 | protein-cofactor linkage (GO:0018065) | 2.50148658 |
| 96 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.48946010 |
| 97 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.48911516 |
| 98 | regulation of viral genome replication (GO:0045069) | 2.46795123 |
| 99 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.44401551 |
| 100 | DNA demethylation (GO:0080111) | 2.44325415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.81053627 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.79591352 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.63839910 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.33455697 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.21822783 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.11688162 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.99941542 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97910842 |
| 9 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.70749717 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.62951818 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.52779577 |
| 12 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.50757234 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.37363877 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.24077459 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.22094751 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.19519372 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.17227330 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15655682 |
| 19 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15432519 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.14832230 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.12991875 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05241524 |
| 23 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.91497414 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87923829 |
| 25 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.86188339 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82109863 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80591573 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79767526 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.77269141 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.76334908 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.69793770 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63759581 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.60752316 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.58640132 |
| 35 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.58014425 |
| 36 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50209173 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.48030100 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.44489517 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44120920 |
| 40 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.43536327 |
| 41 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.43536327 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40882653 |
| 43 | AR_20517297_ChIP-Seq_VCAP_Human | 1.39871171 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38990026 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35792519 |
| 46 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.31489798 |
| 47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.31193320 |
| 48 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.27568431 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.27283983 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26189735 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.24091014 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.23598795 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22458768 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22458768 |
| 55 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21867779 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21867779 |
| 57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20710364 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19927686 |
| 59 | NCOR_22424771_ChIP-Seq_293T_Human | 1.18417005 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15066516 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13857538 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13687618 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13094987 |
| 64 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12469432 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09503182 |
| 66 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09443365 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08123130 |
| 68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08114215 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.07137782 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06465709 |
| 71 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06453203 |
| 72 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05355544 |
| 73 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05171676 |
| 74 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04471353 |
| 75 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.04094341 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04055828 |
| 77 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03080893 |
| 78 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03057712 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02778281 |
| 80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02528137 |
| 81 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02473646 |
| 82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02454409 |
| 83 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01547388 |
| 84 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.00593307 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.00447545 |
| 86 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00372543 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.00298690 |
| 88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.99263787 |
| 89 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.98466505 |
| 90 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98031715 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.97644446 |
| 92 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.97002305 |
| 93 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97000045 |
| 94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96239821 |
| 95 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.95225891 |
| 96 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.93806935 |
| 97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.93167266 |
| 98 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93132204 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92723093 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92112914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.84546929 |
| 2 | MP0002102_abnormal_ear_morphology | 3.16561647 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.11058962 |
| 4 | MP0008877_abnormal_DNA_methylation | 2.64841263 |
| 5 | MP0001188_hyperpigmentation | 2.62201827 |
| 6 | MP0001873_stomach_inflammation | 2.32568125 |
| 7 | MP0009785_altered_susceptibility_to | 2.31944356 |
| 8 | MP0006072_abnormal_retinal_apoptosis | 2.31441011 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.24081548 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.13537139 |
| 11 | MP0000372_irregular_coat_pigmentation | 1.97319380 |
| 12 | MP0003786_premature_aging | 1.86968180 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 1.83934111 |
| 14 | MP0005000_abnormal_immune_tolerance | 1.76896987 |
| 15 | MP0003195_calcinosis | 1.76590951 |
| 16 | MP0008789_abnormal_olfactory_epithelium | 1.74939831 |
| 17 | MP0004147_increased_porphyrin_level | 1.74502795 |
| 18 | MP0008058_abnormal_DNA_repair | 1.72738032 |
| 19 | MP0008995_early_reproductive_senescence | 1.70182683 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.66886165 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.65117722 |
| 22 | MP0009697_abnormal_copulation | 1.64327440 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.63349526 |
| 24 | MP0001905_abnormal_dopamine_level | 1.63071992 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.61350083 |
| 26 | MP0006082_CNS_inflammation | 1.56924211 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.53862831 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.48794489 |
| 29 | MP0002006_tumorigenesis | 1.43581563 |
| 30 | MP0002876_abnormal_thyroid_physiology | 1.43521058 |
| 31 | MP0005253_abnormal_eye_physiology | 1.42651950 |
| 32 | MP0003724_increased_susceptibility_to | 1.42440511 |
| 33 | MP0005389_reproductive_system_phenotype | 1.41984563 |
| 34 | MP0001800_abnormal_humoral_immune | 1.39915019 |
| 35 | MP0002723_abnormal_immune_serum | 1.39201981 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.37788762 |
| 37 | MP0002277_abnormal_respiratory_mucosa | 1.36941294 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.36419520 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.36407129 |
| 40 | MP0003880_abnormal_central_pattern | 1.36398502 |
| 41 | MP0003718_maternal_effect | 1.34576458 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.33502307 |
| 43 | MP0001819_abnormal_immune_cell | 1.31099686 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.28798119 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.27945256 |
| 46 | MP0002736_abnormal_nociception_after | 1.26330182 |
| 47 | MP0005085_abnormal_gallbladder_physiolo | 1.26025111 |
| 48 | MP0002160_abnormal_reproductive_system | 1.23030842 |
| 49 | MP0001529_abnormal_vocalization | 1.22821245 |
| 50 | MP0008872_abnormal_physiological_respon | 1.22445996 |
| 51 | MP0002405_respiratory_system_inflammati | 1.21475707 |
| 52 | MP0001984_abnormal_olfaction | 1.20779351 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.20171921 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.19953841 |
| 55 | MP0001919_abnormal_reproductive_system | 1.19432040 |
| 56 | MP0005025_abnormal_response_to | 1.15716832 |
| 57 | MP0005410_abnormal_fertilization | 1.12337582 |
| 58 | MP0003011_delayed_dark_adaptation | 1.11774287 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07700084 |
| 60 | MP0009046_muscle_twitch | 1.04703529 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.04513139 |
| 62 | MP0000716_abnormal_immune_system | 1.02830817 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.02760468 |
| 64 | MP0003646_muscle_fatigue | 1.02253737 |
| 65 | MP0003137_abnormal_impulse_conducting | 1.01842371 |
| 66 | MP0002452_abnormal_antigen_presenting | 1.00591305 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.00305014 |
| 68 | MP0005499_abnormal_olfactory_system | 0.99625261 |
| 69 | MP0005394_taste/olfaction_phenotype | 0.99625261 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 0.99553703 |
| 71 | MP0002398_abnormal_bone_marrow | 0.99138102 |
| 72 | MP0005360_urolithiasis | 0.98509805 |
| 73 | MP0001853_heart_inflammation | 0.98030418 |
| 74 | MP0009745_abnormal_behavioral_response | 0.96205279 |
| 75 | MP0001929_abnormal_gametogenesis | 0.96158634 |
| 76 | MP0002272_abnormal_nervous_system | 0.95327413 |
| 77 | MP0005174_abnormal_tail_pigmentation | 0.94657342 |
| 78 | MP0009764_decreased_sensitivity_to | 0.93157880 |
| 79 | MP0000703_abnormal_thymus_morphology | 0.92585003 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.89481406 |
| 81 | MP0005387_immune_system_phenotype | 0.88085357 |
| 82 | MP0001790_abnormal_immune_system | 0.88085357 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.87364280 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.87145357 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.86917121 |
| 86 | MP0001661_extended_life_span | 0.86584220 |
| 87 | MP0010155_abnormal_intestine_physiology | 0.86292747 |
| 88 | MP0002210_abnormal_sex_determination | 0.86248479 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.85736495 |
| 90 | MP0003866_abnormal_defecation | 0.84794309 |
| 91 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84000990 |
| 92 | MP0002722_abnormal_immune_system | 0.83263809 |
| 93 | MP0003252_abnormal_bile_duct | 0.82831446 |
| 94 | MP0006276_abnormal_autonomic_nervous | 0.82555150 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.81761024 |
| 96 | MP0002638_abnormal_pupillary_reflex | 0.81382079 |
| 97 | MP0001119_abnormal_female_reproductive | 0.79273400 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.79008779 |
| 99 | MP0002429_abnormal_blood_cell | 0.77589689 |
| 100 | MP0008057_abnormal_DNA_replication | 0.76976143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.71323959 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.61698331 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.42979604 |
| 4 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.16353222 |
| 5 | Acute encephalopathy (HP:0006846) | 3.94741603 |
| 6 | Increased CSF lactate (HP:0002490) | 3.89215706 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.88211479 |
| 8 | 3-Methylglutaconic aciduria (HP:0003535) | 3.80104685 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.76920436 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.61561220 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51218079 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 3.42334089 |
| 13 | T lymphocytopenia (HP:0005403) | 3.38228349 |
| 14 | Cerebral edema (HP:0002181) | 3.35624222 |
| 15 | Hepatic necrosis (HP:0002605) | 3.30820371 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.27961747 |
| 17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.25811250 |
| 18 | IgG deficiency (HP:0004315) | 3.25767385 |
| 19 | Pancreatic cysts (HP:0001737) | 3.17631864 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.14081487 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.14081487 |
| 22 | Abnormality of T cell number (HP:0011839) | 3.12878577 |
| 23 | Renal Fanconi syndrome (HP:0001994) | 3.00059758 |
| 24 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.88176008 |
| 25 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.88176008 |
| 26 | Decreased central vision (HP:0007663) | 2.79622306 |
| 27 | Hypoproteinemia (HP:0003075) | 2.76554912 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 2.75879152 |
| 29 | Optic disc pallor (HP:0000543) | 2.75118935 |
| 30 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66491954 |
| 31 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.62365761 |
| 32 | Type I transferrin isoform profile (HP:0003642) | 2.60253708 |
| 33 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.54904631 |
| 34 | Combined immunodeficiency (HP:0005387) | 2.54671186 |
| 35 | Congenital, generalized hypertrichosis (HP:0004540) | 2.54341005 |
| 36 | Increased serum lactate (HP:0002151) | 2.51848328 |
| 37 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.51515707 |
| 38 | Exertional dyspnea (HP:0002875) | 2.51282129 |
| 39 | Attenuation of retinal blood vessels (HP:0007843) | 2.46220970 |
| 40 | Respiratory failure (HP:0002878) | 2.44378359 |
| 41 | Lactic acidosis (HP:0003128) | 2.41729312 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.39912788 |
| 43 | Congenital stationary night blindness (HP:0007642) | 2.39829645 |
| 44 | Abolished electroretinogram (ERG) (HP:0000550) | 2.37769571 |
| 45 | True hermaphroditism (HP:0010459) | 2.37698792 |
| 46 | Thyroiditis (HP:0100646) | 2.35852678 |
| 47 | Type II lissencephaly (HP:0007260) | 2.35722981 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.35457579 |
| 49 | Increased muscle lipid content (HP:0009058) | 2.33069243 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.20959143 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.20805011 |
| 52 | B lymphocytopenia (HP:0010976) | 2.18777521 |
| 53 | Lethargy (HP:0001254) | 2.14753839 |
| 54 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.14385120 |
| 55 | Abnormality of T cells (HP:0002843) | 2.12949359 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.09631840 |
| 57 | Exercise intolerance (HP:0003546) | 2.08957944 |
| 58 | Pendular nystagmus (HP:0012043) | 2.07255321 |
| 59 | Abnormality of urine glucose concentration (HP:0011016) | 2.07207520 |
| 60 | Glycosuria (HP:0003076) | 2.07207520 |
| 61 | Nephronophthisis (HP:0000090) | 2.01798362 |
| 62 | Chronic diarrhea (HP:0002028) | 2.00268518 |
| 63 | Increased IgM level (HP:0003496) | 1.97146857 |
| 64 | Posterior subcapsular cataract (HP:0007787) | 1.96252579 |
| 65 | Hypothermia (HP:0002045) | 1.94556392 |
| 66 | Leukodystrophy (HP:0002415) | 1.94172758 |
| 67 | Abnormality of renal resorption (HP:0011038) | 1.94135066 |
| 68 | Short tibia (HP:0005736) | 1.93725250 |
| 69 | Stomatitis (HP:0010280) | 1.93104535 |
| 70 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92385563 |
| 71 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92385563 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 1.92385563 |
| 73 | Abnormal glycosylation (HP:0012345) | 1.92385563 |
| 74 | Abnormality of eosinophils (HP:0001879) | 1.91507695 |
| 75 | Pancytopenia (HP:0001876) | 1.90129140 |
| 76 | Median cleft lip (HP:0000161) | 1.89454755 |
| 77 | Methylmalonic acidemia (HP:0002912) | 1.85601472 |
| 78 | Renal cortical cysts (HP:0000803) | 1.84701702 |
| 79 | X-linked dominant inheritance (HP:0001423) | 1.79236146 |
| 80 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.78618304 |
| 81 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.75718377 |
| 82 | Gangrene (HP:0100758) | 1.74388809 |
| 83 | Parakeratosis (HP:0001036) | 1.73789961 |
| 84 | Alveolar cell carcinoma (HP:0006519) | 1.72659227 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 1.71837501 |
| 86 | Respiratory difficulties (HP:0002880) | 1.71215433 |
| 87 | Methylmalonic aciduria (HP:0012120) | 1.70895680 |
| 88 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.69174215 |
| 89 | Optic neuritis (HP:0100653) | 1.68931223 |
| 90 | Retrobulbar optic neuritis (HP:0100654) | 1.68931223 |
| 91 | Spastic paraparesis (HP:0002313) | 1.68393586 |
| 92 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68198597 |
| 93 | Hypoplasia of the fovea (HP:0007750) | 1.68198597 |
| 94 | Abnormality of the fovea (HP:0000493) | 1.67924837 |
| 95 | Reduced antithrombin III activity (HP:0001976) | 1.66823630 |
| 96 | Hyperphosphaturia (HP:0003109) | 1.66808445 |
| 97 | Abnormal albumin level (HP:0012116) | 1.66195873 |
| 98 | Hypoalbuminemia (HP:0003073) | 1.66195873 |
| 99 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65067733 |
| 100 | Hypoplasia of the uterus (HP:0000013) | 1.64378794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.76637525 |
| 2 | KDR | 3.65882946 |
| 3 | TESK2 | 3.16892931 |
| 4 | NUAK1 | 3.12222358 |
| 5 | VRK2 | 3.05984122 |
| 6 | MAP4K2 | 3.04823826 |
| 7 | BCKDK | 2.97539921 |
| 8 | EIF2AK3 | 2.41637661 |
| 9 | TIE1 | 2.30940387 |
| 10 | BUB1 | 2.23202031 |
| 11 | VRK1 | 2.21444284 |
| 12 | ZAK | 2.15221399 |
| 13 | PINK1 | 2.13774355 |
| 14 | ADRBK2 | 2.13179544 |
| 15 | TAOK3 | 1.90473280 |
| 16 | GRK1 | 1.89806899 |
| 17 | MST4 | 1.87727150 |
| 18 | FES | 1.71780827 |
| 19 | TLK1 | 1.67439757 |
| 20 | CDK19 | 1.65062898 |
| 21 | MAP3K12 | 1.43340628 |
| 22 | TEC | 1.40266650 |
| 23 | SRPK1 | 1.37047335 |
| 24 | PLK4 | 1.36158042 |
| 25 | ITK | 1.26734542 |
| 26 | OXSR1 | 1.26276371 |
| 27 | FRK | 1.25654196 |
| 28 | TESK1 | 1.23540083 |
| 29 | CSNK1G1 | 1.18306600 |
| 30 | CSNK1G3 | 1.14594486 |
| 31 | TRIM28 | 1.12666214 |
| 32 | SCYL2 | 1.11052864 |
| 33 | CDC7 | 1.08929001 |
| 34 | BMPR2 | 1.03007686 |
| 35 | WNK4 | 0.99204857 |
| 36 | PRKCQ | 0.98600979 |
| 37 | GRK6 | 0.94426811 |
| 38 | CSNK1A1L | 0.93261360 |
| 39 | INSRR | 0.93126520 |
| 40 | RPS6KA4 | 0.91162776 |
| 41 | STK39 | 0.90950714 |
| 42 | IKBKB | 0.87706164 |
| 43 | WNK3 | 0.86436603 |
| 44 | PLK3 | 0.82241913 |
| 45 | LIMK1 | 0.81067097 |
| 46 | CSK | 0.80663411 |
| 47 | CSNK1G2 | 0.80479348 |
| 48 | DAPK1 | 0.79461056 |
| 49 | LCK | 0.76235157 |
| 50 | MAP4K1 | 0.76227676 |
| 51 | MATK | 0.74978841 |
| 52 | RPS6KA5 | 0.73216340 |
| 53 | PLK2 | 0.69562119 |
| 54 | ERBB3 | 0.68744102 |
| 55 | MAPKAPK3 | 0.67090637 |
| 56 | BCR | 0.66079916 |
| 57 | EIF2AK2 | 0.65055301 |
| 58 | LYN | 0.62981771 |
| 59 | SYK | 0.62960470 |
| 60 | NEK1 | 0.61999812 |
| 61 | MYLK | 0.61638272 |
| 62 | BMPR1B | 0.61630857 |
| 63 | PIM2 | 0.53688234 |
| 64 | GRK7 | 0.51752661 |
| 65 | MAPK13 | 0.49689779 |
| 66 | MAP2K6 | 0.49631378 |
| 67 | KIT | 0.47859601 |
| 68 | CSNK1A1 | 0.47025292 |
| 69 | BTK | 0.46717782 |
| 70 | ATR | 0.44220371 |
| 71 | CAMKK2 | 0.43329344 |
| 72 | DYRK3 | 0.43321827 |
| 73 | ARAF | 0.43160384 |
| 74 | PLK1 | 0.42811954 |
| 75 | STK16 | 0.42628211 |
| 76 | PRKACA | 0.41717021 |
| 77 | CSNK2A1 | 0.41695792 |
| 78 | CAMK2A | 0.40928360 |
| 79 | PRKCE | 0.40427452 |
| 80 | CSNK2A2 | 0.40146748 |
| 81 | NME1 | 0.40109708 |
| 82 | DYRK2 | 0.39896892 |
| 83 | PIM1 | 0.39689515 |
| 84 | OBSCN | 0.37766119 |
| 85 | CLK1 | 0.37644310 |
| 86 | AURKB | 0.37266969 |
| 87 | MUSK | 0.36130847 |
| 88 | RAF1 | 0.35985204 |
| 89 | MKNK1 | 0.35853763 |
| 90 | MINK1 | 0.35214848 |
| 91 | PRKCA | 0.34097783 |
| 92 | INSR | 0.32372074 |
| 93 | ROCK1 | 0.31749817 |
| 94 | IGF1R | 0.31718694 |
| 95 | AURKA | 0.30857895 |
| 96 | MAPKAPK5 | 0.28856013 |
| 97 | PRKCG | 0.28764037 |
| 98 | ADRBK1 | 0.26605186 |
| 99 | PAK1 | 0.26108989 |
| 100 | PIK3CG | 0.25685306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.97553364 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.69662019 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.24607872 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.17728396 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.10287429 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.91138534 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.29700921 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.24116830 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.06466707 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.04940548 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.02099709 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95814960 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85832868 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.80471783 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.73309890 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.68762091 |
| 17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.67533102 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.67256213 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56786530 |
| 20 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.48871524 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48676357 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43367613 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41197462 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38700373 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36918447 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.34853700 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34662402 |
| 28 | RNA degradation_Homo sapiens_hsa03018 | 1.29763751 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.27998562 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.27777894 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.25572438 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24286046 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21342359 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.19789789 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.17368802 |
| 36 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17122377 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.14591314 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06630717 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.06299326 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.05450774 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.01261854 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00345198 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99380935 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.98490924 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98434563 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95681699 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94834052 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 0.92722514 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89851324 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 0.89669658 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87319320 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77151689 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.75490170 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75187527 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74380939 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72836655 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72795772 |
| 58 | DNA replication_Homo sapiens_hsa03030 | 0.72294049 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70191363 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68104214 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.67866777 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66572912 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64882550 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64508976 |
| 65 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62276609 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62263179 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61723805 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61506356 |
| 69 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60917159 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60693196 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59642090 |
| 72 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58420955 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56314475 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55174658 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55165988 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54677874 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53552211 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53515413 |
| 79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52364527 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47496882 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.46068168 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44059653 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.43605600 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43146323 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43018476 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42312991 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.41491651 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40982400 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40975731 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40926461 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.39040863 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38570524 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.37218677 |
| 94 | Measles_Homo sapiens_hsa05162 | 0.37040341 |
| 95 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36053850 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34169744 |
| 97 | Taste transduction_Homo sapiens_hsa04742 | 0.31538828 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.28632606 |
| 99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.26452421 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.25325921 |

